Nasogastric Tube Market
By Nasogastric Tube Type (Levin Catheter, Dobhoff Tube, Moss Tube, and Others),
By Patient (Paediatric, Adult),
By Application (Oncology, Gastroenterology. Diabetes, and Others),
By End Use (Hospitals, Clinics, Home Care),
By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa):
Global Analysis and Forecast 2023-2033
The global Nasogastric Tube Market is to be worth more than USD 1,426.5 million by 2033.
Nasogastric tubes are used for feeding patients who are unable to eat themselves. Liquid or pureed food preparations and liquid medications are delivered using nasogastric tubes. These tubes enter through the nose and reach the stomach. Recent years have witnessed a rise in the Geriatric population and chronic disorders. Older populations become dependent on feeding and other nature calls. Chronic disorders like stroke or associated paralysis attacks fuel more demand for nasogastric feeding. Recent years have witnessed a drastic rise in cancer cases and preterm births. All these factors collectively drive the market demand for nasogastric tubes.
Further innovation in insertion procedures and safer material usage are also propelling more market opportunities for nasogastric tubes. Biocompatible and flexible materials are used for manufacturing nasogastric tubes to increase patient compliance. Many professionals have curated special guidelines for insertion procedures to keep patient compliance and success rates high.
The companies operating within the nasogastric tube industry are undergoing mergers, collaboration, acquisition, long-term contracts, and service agreements to increase their global footprint. For instance, Vonco Products Receives FDA 510(k) Clearance for Novel Closed-Loop Enteral Feeding Solution - EnteraLoc™ Flow. This approval would allow the market to use novel enteral feeding solutions, further expanding market growth for the company. Furthermore, notable investment towards research and development to launch new and innovative products that industry stakeholders also practice Patient compliance at multiple levels.
According to the CXOs and primary research conducted, COVID-19 Pandemic has significantly impacted the market growth for nasogastric tubes. The pandemic presented with a severe infection, making patients rely on nasogastric feeding. Hospitals saw a surge in demand for beds, oxygen, and also other equipment, including nasogastric tubes. Patients with chronic disorders got even more prone to severe outcomes. Stress due to professional blockage also resulted in the acceleration of chronic disorders. These factors collectively fuelled the market growth for nasogastric tubes.
The nasogastric tube market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In line with the analyzed region, the North American region will witness the highest market share, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. Quick adoption of new technologies to increase patient compliance, support by hospital policies and guidelines towards care of cancer patients and preterm births, and the presence of major industry players within the region are primary factors supporting market potential within the North American region. The major companies operating within the market are Andersen Products, Bard Medical, Becton, Dickinson and Company, Cardinal Health, Degania Medical, Guangdong Baihe Medical Technology Co., Ltd., Hangzhou Formed Medical Devices Co., Ltd., Pacific Hospital Supply Co., Ltd., Rontis Medical and SecurMed.